The pharmacovigilance of psychoactive medications in Brazil

OBJETIVE: The present study aimed to analyze 219 notifications of suspected adverse reactions (AR) produced by psychoactive medicaments (ARPM), notified by Brazilian psychiatrists, during a 3-month period (April 1999 up to September 2001). METHOD: A notifying card for adverse reactions possibly produced by psychoactive medications was quarterly sent to all psychiatrists affiliated to the Brazilian Association of Psychiatry. Once each notification, dully filled in, was received, the possible adverse reaction was analyzed in order to verify the causality RESULTS: The psychiatrists classified as severe 50 of the ARPMs; 150 others were not considered as severe. Among the severe ones there were 3 deaths, 12 life-threatening reactions, 26 ARPMs required or prolonged hospitalization and 9 notifications described temporary disability of the patients. Among the medications, antidepressants ranked first with 122 ARPMs being notified, followed by neuroleptics (46 ARPMs) and antiepiletic medicaments (25 ARPMs). The three main organs and systems affected by the ARs were the Central Nervous System with 102 ARs, skin and mucosa with 44 and gastrointestinal with 21 ARPMs. CONCLUSION: Considering causality, i.e., the association between the medication and the described AR, 24 cases were considered as Definite (with positive dechallenge and rechallenge, i.e., withdrawal and reintroduction of the medication) and 134 other ARPMs were classified as Probable (only dechallenge positive; only with medication withdrawal; rechallenge was not performed).

Saved in:
Bibliographic Details
Main Authors: Carlini,Elisaldo Luiz de Araújo, Nappo,Solange Aparecida
Format: Digital revista
Language:English
Published: Associação Brasileira de Psiquiatria 2003
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462003000400004
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1516-44462003000400004
record_format ojs
spelling oai:scielo:S1516-444620030004000042004-01-16The pharmacovigilance of psychoactive medications in BrazilCarlini,Elisaldo Luiz de AraújoNappo,Solange Aparecida Adverse reaction to medicines Pharmacovigilance Psychoactive medicaments Causality of adverse drug reactions OBJETIVE: The present study aimed to analyze 219 notifications of suspected adverse reactions (AR) produced by psychoactive medicaments (ARPM), notified by Brazilian psychiatrists, during a 3-month period (April 1999 up to September 2001). METHOD: A notifying card for adverse reactions possibly produced by psychoactive medications was quarterly sent to all psychiatrists affiliated to the Brazilian Association of Psychiatry. Once each notification, dully filled in, was received, the possible adverse reaction was analyzed in order to verify the causality RESULTS: The psychiatrists classified as severe 50 of the ARPMs; 150 others were not considered as severe. Among the severe ones there were 3 deaths, 12 life-threatening reactions, 26 ARPMs required or prolonged hospitalization and 9 notifications described temporary disability of the patients. Among the medications, antidepressants ranked first with 122 ARPMs being notified, followed by neuroleptics (46 ARPMs) and antiepiletic medicaments (25 ARPMs). The three main organs and systems affected by the ARs were the Central Nervous System with 102 ARs, skin and mucosa with 44 and gastrointestinal with 21 ARPMs. CONCLUSION: Considering causality, i.e., the association between the medication and the described AR, 24 cases were considered as Definite (with positive dechallenge and rechallenge, i.e., withdrawal and reintroduction of the medication) and 134 other ARPMs were classified as Probable (only dechallenge positive; only with medication withdrawal; rechallenge was not performed).info:eu-repo/semantics/openAccessAssociação Brasileira de PsiquiatriaBrazilian Journal of Psychiatry v.25 n.4 20032003-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462003000400004en10.1590/S1516-44462003000400004
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Carlini,Elisaldo Luiz de Araújo
Nappo,Solange Aparecida
spellingShingle Carlini,Elisaldo Luiz de Araújo
Nappo,Solange Aparecida
The pharmacovigilance of psychoactive medications in Brazil
author_facet Carlini,Elisaldo Luiz de Araújo
Nappo,Solange Aparecida
author_sort Carlini,Elisaldo Luiz de Araújo
title The pharmacovigilance of psychoactive medications in Brazil
title_short The pharmacovigilance of psychoactive medications in Brazil
title_full The pharmacovigilance of psychoactive medications in Brazil
title_fullStr The pharmacovigilance of psychoactive medications in Brazil
title_full_unstemmed The pharmacovigilance of psychoactive medications in Brazil
title_sort pharmacovigilance of psychoactive medications in brazil
description OBJETIVE: The present study aimed to analyze 219 notifications of suspected adverse reactions (AR) produced by psychoactive medicaments (ARPM), notified by Brazilian psychiatrists, during a 3-month period (April 1999 up to September 2001). METHOD: A notifying card for adverse reactions possibly produced by psychoactive medications was quarterly sent to all psychiatrists affiliated to the Brazilian Association of Psychiatry. Once each notification, dully filled in, was received, the possible adverse reaction was analyzed in order to verify the causality RESULTS: The psychiatrists classified as severe 50 of the ARPMs; 150 others were not considered as severe. Among the severe ones there were 3 deaths, 12 life-threatening reactions, 26 ARPMs required or prolonged hospitalization and 9 notifications described temporary disability of the patients. Among the medications, antidepressants ranked first with 122 ARPMs being notified, followed by neuroleptics (46 ARPMs) and antiepiletic medicaments (25 ARPMs). The three main organs and systems affected by the ARs were the Central Nervous System with 102 ARs, skin and mucosa with 44 and gastrointestinal with 21 ARPMs. CONCLUSION: Considering causality, i.e., the association between the medication and the described AR, 24 cases were considered as Definite (with positive dechallenge and rechallenge, i.e., withdrawal and reintroduction of the medication) and 134 other ARPMs were classified as Probable (only dechallenge positive; only with medication withdrawal; rechallenge was not performed).
publisher Associação Brasileira de Psiquiatria
publishDate 2003
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462003000400004
work_keys_str_mv AT carlinielisaldoluizdearaujo thepharmacovigilanceofpsychoactivemedicationsinbrazil
AT napposolangeaparecida thepharmacovigilanceofpsychoactivemedicationsinbrazil
AT carlinielisaldoluizdearaujo pharmacovigilanceofpsychoactivemedicationsinbrazil
AT napposolangeaparecida pharmacovigilanceofpsychoactivemedicationsinbrazil
_version_ 1756422553695420416